QQQM invests in US large-cap companies, tracking its benchmark, the NASDAQ-100 index. See why I rate the fund a hold.

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could ...

Nasdaq's improved debt position doesn’t justify a rating upgrade. Read why NDAQ stock remains a Hold with potential for ...

Nvidia's stock outperforms despite high P/E, the Direxion Daily NVDA Bull 2X Shares ETF offers amplified returns and risks.

The popular phrase "reports of my death are greatly exaggerated," an adaptation of a famous Mark Twain quote, is a terrific ...

Lam Research's Q2-2025 earnings beat expectations, with strong revenue and EPS growth. Read why I remain neutral on LRCX ...

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) has earned an average recommendation of “Buy” from the five ratings firms that are covering the company, Marketbeat reports. Five ...

Analyst evaluates Nutanix's growth prospects, cost pressures, and stock valuation in light of earnings growth and industry ...

Financial writer highlights ASML Holding N.V.'s growth potential, strong Q4 results, share buyback program, and solid market ...

Holding shares of QQQI in a portfolio will be the best way to play the looming volatility in 2025 says this author. Here's why.

Apple's current stock price doesn't offer outsized returns, so it might be better to wait for a dip. Learn why AAPL stock is ...

Apple's FY Q1 2025 earnings exceeded expectations, but I see good odds for a downward surprise in its upcoming FY Q2 2025 ...